It seems to me that we're in a predictable cycle where

New Post Public Reply Private Reply Replies (0) Message Board
GaryM
522
It seems to me that we're in a predictable cycle where anticipation of news grows as we head for a weekend and continues through Monday, then tapers off over the middle of the week. One could trade on this cycle, selling at higher levels achieved on Monday, and buying at lower levels on Thursday.

Such action might be profitable most weeks, but the problem is, what if great news comes in after selling on Monday. As I see it, their is no guarantee that news couldn't come any day.

Many years ago a stock broker friend told me that companies try to put out good news early in the week, to get the best brokerage participation, but not necessarily on Monday's if the feeling is many broker's may be taking long weekends. Bad news they clearly like to dump after the close on Friday, and if possible on a 3 day weekend. I suspect what he said then is still the case, but in the electronic world we live in today, both good and bad news are rapidly viewed by the investing public.

I won't say that a company cannot plan when a clinical trial will end, but it does take time to organize the data once its unblinded, and I don't believe it can be timed to occur precisely on one day. The company certainly has some time to put together a proper release, so some degree of control can be taken, but I don't think a release would be delayed if it couldn't be made before the open on Monday or Tuesday, and I don't think it must come before the market opens. In that all the real work is being done in Israel, it wouldn't be a surprise to me if news came in a presentation there during the day, which probably would correspond with late night here.

I believe if you choose to trade the cycle, you risk being out when a tremendous gain is made on positive news and given today's low prices, you might have to pay 5 to 10 times the current price to get back into the stock.

Gary

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Next PR Unveils Cutting-Edge AI Optimization Solutions

Updated Category News Views 208

Next PR Launches Innovative AI Optimization Services Next PR, an award-winning public relations firm, has recently introduced its AI Optimization Services, aimed at helping brands maintain visibility and authority in today's AI-driven digital landscape. As companies strive to adapt to the ever-changing world of artificial intelligence and search engine results generated...

Continue Reading
Security and Vulnerability Management Market Set for Growth Surge

Updated Category News Views 144

Overview of the Security and Vulnerability Management Market The Security and Vulnerability Management Market is on an impressive trajectory, predicted to expand from USD 17.55 billion to USD 24.07 billion by 2030, reflecting significant growth propelled by rising global vulnerabilities. Market Growth Drivers Multiple factors are contributing to this market's growth....

Continue Reading
Bybit Unveils Groundbreaking MiCAR-Compliant Platform for Europe

Updated Category News Views 275

Introducing Bybit.eu: A New Era for European Crypto Users Bybit, a leader in the cryptocurrency exchange market and the world's second-largest by trading volume, is evolving by launching Bybit.eu. This fully MiCAR-compliant platform is crafted specifically for users across the European Economic Area (EEA). Bybit EU GmbH operates this platform as a licensed Crypto-Asset...

Continue Reading
Breakthrough Updates on NXP900 Clinical Development Journey

Updated Category News Views 128

Nuvectis Pharma Reports Significant NXP900 Findings Nuvectis Pharma, Inc. (NASDAQ: NVCT), known for its pioneering work in oncology, has shared key insights regarding NXP900 at a recent prestigious cancer research meeting. This innovative drug shows considerable promise in treating advanced cancers. Based on a Phase 1a dose-escalation study, NXP900 demonstrated strong...

Continue Reading
Elon Musk's Heartfelt Christmas Eve Adventure in Snowy Cold

Updated Category News Views 323

The Unexpected Christmas Quest of Elon Musk Christmas is a time when many cherish the joy of giving and receiving gifts. However, when you are someone like Elon Musk, a dynamic CEO known for pushing boundaries with Tesla and SpaceX, a forgotten gift can turn into an extraordinary adventure. Imagine waking on Christmas Eve only to realize that you forgot to buy your...

Continue Reading